References
- Shahbaz SarwarCMLuketichJDLandreneauRJAbbasGEsophageal cancer: an updateInt J Surg20108641742220601255
- JemalASiegelRWardECancer statistics, 2009CA Cancer J Clin200959422524919474385
- AndersonLLLadTEAutopsy findings in squamous-cell carcinoma of the esophagusCancer1982508158715907116290
- ChanKWChanEYChanCWCarcinoma of the esophagus. An autopsy study of 231 casesPathology19861844004053822518
- CooperJSGuoMDHerskovicAChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology GroupJAMA1999281171623162710235156
- MinskyBDPajakTFGinsbergRJINT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyJ Clin Oncol20022051167117411870157
- KuGYIlsonDHEsophagogastric cancer: targeted agentsCancer Treat Rev201036323524820122806
- MalthanerRWongRKSpithoffKPreoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guidelineClin Oncol (R Coll Radiol)201022425025620398848
- HenryLRGoldbergMScottWInduction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a Phase II reportAnn Surg Oncol200613221422016418887
- JatoiAMartensonJMahoneyMRResults of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment GroupInt Semin Surg Oncol200411915533252
- MeluchAAGrecoFAGrayJRPreoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network Phase II trialCancer J20039425126012967135
- SeungSKSmithJWMolendykJSelective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensificationSemin Oncol2004316 Suppl 18131915726517
- UrbaSGOrringerMBIanettonniMConcurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinomaCancer200398102177218314601087
- TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
- HamaguchiTMatsumuraYSuzukiMNK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBr J Cancer20059271240124615785749
- LeeKSChungHCImSAMulticenter Phase II trial of Genexol- PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerBreast Cancer Res Treat2008108224125017476588
- ChipmanSDOldhamFBPezzoniGSingerJWBiological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugateInt J Nanomedicine2006137538317722272
- YangDVanSJiangXYuLNovel free paclitaxel-loaded poly(L-gamma-glutamylglutamine)-paclitaxel nanoparticlesInt J Nanomedicine20116859121289985
- WangFChenYZhangDFolate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-Ocarboxymethylated chitosan-folic acid micellesInt J Nanomedicine2012732533722287842
- WernerMEKarveSSukumarRFolate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasisBiomaterials201132338548855421843904
- LeeRJLowPSFolate-mediated tumor cell targeting of liposome- entrapped doxorubicin in vitroBiochim Biophys Acta1995123321341447865538
- KamenBASmithAKA review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitroAdv Drug Deliv Rev20045681085109715094208
- ChenSZLiuXZGuoGHResearch on expression of folate receptor alpha and its correlation with clinicopathology in esophageal carcinomaJournal of Practical Oncology2008233200205
- HuangLHuJLangLSynthesis and characterization of electroactive and biodegradable ABA block copolymer of polylactide and aniline pentamerBiomaterials200728101741175117218007
- TianHYDengCLinHBiodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: synthesis and micelle characterizationBiomaterials200526204209421715683643
- DengCTianHZhangPSynthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymerBiomacromolecules20067259059616471935
- LuTSunJChenXFolate-conjugated micelles and their folate-receptor-mediated endocytosisMacromol Biosci20099111059106819688723
- ZhangXLiYChenXSynthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugateBiomaterials200526142121212815576187
- XieZHuXChenXSynthesis and characterization of novel biodegradable poly(carbonate ester)s with photolabile protecting groupsBiomacromolecules20089137638018067260
- LiQZhuJSunFOncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3Int J Mol Med201128110110821399864
- MaPLiuSHuangYLactose mediated liver-targeting effect observed by ex vivo imaging technologyBiomaterials20103192646265420036420
- ZhengYWanYSongXComposite micelles consisting of paclitaxel- and folic acid-carrying copolymers for treatment of Lewis lung cancerJ Control Release2011152Suppl 1e123e12422195794
- HattoriYMaitaniYEnhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancerJ Control Release200497117318315147814
- ZhaoDZhaoXZuYPreparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticlesInt J Nanomedicine2010566967720957218
- WehbrinkDHassigMRitterNImmunohistochemical demonstration of cyclooxygenase-2 (COX-2) and prostaglandin receptors EP2 and FP expression in the bovine intercaruncular uterine wall around termAnim Reprod Sci20081063–424125417574782
- YinCKnudsonCMKorsmeyerSJVan DykeTBax suppresses tumorigenesis and stimulates apoptosis in vivoNature199738566176376409024662
- JurgensmeierJMXieZDeverauxQBax directly induces release of cytochrome c from isolated mitochondriaProc Natl Acad Sci U S A1998959499750029560217
- SzumiloJChibowskiDAAssessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinomaDis Esophagus200013319119711206631
- KangSYHanJHLeeKJLow expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapyClin Cancer Res200713144146415317634542
- JohnstoneRWRuefliAALoweSWApoptosis: a link between cancer genetics and chemotherapyCell2002108215316411832206
- IsmailNPihieAHNallapanMXanthorrhizol induces apoptosis via the up-regulation of Bax and p53 in HeLa cellsAnticancer Res2005253B2221222716158967
- HsiaJYChenCYChenJTPrognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinomaEur J Surg Oncol2003291444812559076
- JiangHGongMCuiYUpregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern ChinaDis Esophagus201023648749220113321
- SalvesenGSCaspases: opening the boxes and interpreting the arrowsCell Death Differ2002913511803369
- GhavamiSHashemiMAndeSRApoptosis and cancer: mutations within caspase genesJ Med Genet200946849751019505876
- JersmannHPRossKAViversSPhagocytosis of apoptotic cells by human macrophages: analysis by multiparameter flow cytometryCytometry A200351171512500300